The largest database of trusted experimental protocols

Serum free media

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom

Serum-free media is a type of cell culture media that does not contain animal-derived serum. It is designed to support the growth and maintenance of cells in vitro without the use of serum. The core function of serum-free media is to provide a defined and controlled environment for cell culture, allowing for more consistent and reproducible results.

Automatically generated - may contain errors

25 protocols using serum free media

1

Liposome Spiked Serum-Free Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum Free Media (Medium 171, Life Technologies, USA) was obtained and passed through a 0.22 µm filter to eliminate contaminating debris. Fluorescin-labelled liposomes (Formumax, USA) were spiked into the filtered media at a dilution of 1:500, and dispensed into 2 mL aliquots. Negative controls consisting of filtered media without liposomes added were also separated into 2 mL aliquots. For exosome samples, BT474 cell culture media was collected and dispensed into 2 mL aliquots for processing.
+ Open protocol
+ Expand
2

Xenograft Tumor Model for Evaluating Anticancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
MiaPaCa-2 xenograft tumours were established subcutaneously in 6−7 week old female NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice (bred at the Institute of Cancer Research (ICR) London). Animals were housed in specific pathogen-free rooms in autoclaved, aseptic microisolator cages with a maximum of five animals per cage. A total of 8 × 106 cells (WT miR-1307 and KO miR-1307) in 80% Matrigel (BD Biosciences, UK) and 20% serum-free media (Life Technologies, Paisley, UK) were injected in a single flank (Supplementary Fig. 5). Three weeks post-inoculation, mice (n = 16) were randomly grouped for initiation of treatment with weekly intraperitoneal (i.p.) administration of oxaliplatin (3 mg/kg), fluorouracil (25 mg/kg), and irinotecan (25 mg/kg) or vehicle (saline) alone for three weeks. Tumour volumes and mouse body weights were determined at regular intervals. Tumours were removed, weighed, and extracted for paraffin embedding. The study was performed in accordance with the UK Home Office regulations under the Animals Scientific Procedures Act 1986 and in accordance with UK National Cancer Research Institute guidelines and the NCRI guidelines49 (link),50 (link). The maximal tumour size/burden allowed (17 mm) was never exceeded.
+ Open protocol
+ Expand
3

Production and Purification of Anti-SEB mAbs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c mice were immunized with recombinant SEB produced using BEVS, and hybridomas were generated as described previously [35 (link)]. A panel of hybridomas was screened to select mAbs binding to recombinant SEB via ELISA. Each hybridoma clone secreting a candidate anti-SEB mAb was confluently cultured in a 6-well plate, and total RNA was extracted to synthesize cDNA using random hexamer primers. For PCR amplification of the antibody VH or VL chain, forward and reverse primer sets were synthesized and used as described previously [36 (link)]. Amplicons corresponding to the VH or VL chain were gel-purified and subcloned into pGEM-T Easy Vector (Promega). Colony PCR was performed to determine the correct insertion of the VH or VL gene, and sequencing analysis was conducted by Bioneer. For mAb production, hybridomas were cultured in 100 mL serum-free media (Gibco) for 5 days, and the supernatants were harvested by centrifugation at 4000× g for 30 min and filtered through a 0.22-μm syringe filter. The mAbs were purified using HiTrapTM MabSelectTM PrismA column (GE Healthcare) equipped with ÄKTA purifier 100 (GE Healthcare).
+ Open protocol
+ Expand
4

Characterizing ctr1, ctr2 and atox1 promoters

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to clone the ctr1, ctr2 and atox1 promoters and characterize their function, yellow catfish were purchased from a local farm (Wuhan, China). HEK293T cells were obtained from the Cell Resource Center in the Fishery College of HZAU. The Lipofectamine 293 and LightShift Chemiluminescent EMSA Kit were purchased from Beyotime Biotechnology (Shanghai, China); Passive Lysis Buffer and Dual-Luciferase from Promega (Minneapolis, MN, USA); and 0.25% trypsin-EDTA, Dulbecco’s Modified Eagle’s Medium (DMEM), Serum-Free Media, Serum-Free Cell Freezing Medium and fetal bovine serum (FBS) from Gibco (Waltham, MA, USA). The Pierce BCA protein assay kit, Trizol reagent and the Reverse Transcription Kit were from Thermo Fisher Scientific (Waltham, MA, USA).
+ Open protocol
+ Expand
5

RNAi Knockdown of Target Genes in Drosophila

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the RNAi knockdown of target genes, dsRNA of 500bp in length was prepared using the New England Biological T7 HiScribe kit (NEB) and purified using RNAzol (Sigma). Four wells in a 6-well plate were spotted with 15μg of dsRNA for each dsRNA target and 1×106 DL1 cells [12 (link)] from Drosophila melanogaster were added in 1 mL of serum free media (Gibco) and incubated for 1 hour at 27°C before the addition of 2mL media containing 10% FBS. These cells were then incubated for 60 hours at 27°C before harvesting. Total RNA was extracted from cells in three replicates of each series using the standard TRIzol extraction protocol (Invitrogen) and resuspended in water to a concentration of 500 μg/μL. The final well in each replicate was harvested using RIPA buffer for protein Western analysis of target protein knockdown verification.
+ Open protocol
+ Expand
6

Hybridoma Generation from PBMC B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight days following plating of PBMCs, wells identified to contain positive B cells by ELISA were selected for electrofusion to generate hybridomas as previously described (24 , 25 ). Hybridomas were plated in 384-well plates for HAT selection, and grown for 14 days at 37°C, 5% CO2. Following screening by ELISA, hybridomas were single-cell sorted using a MoFlo Astrios cell sorter using live/dead staining by propidium iodide. The sorted hybridomas were cultured in 25% Media E (StemCell) + 75% Media A (StemCell) for two weeks, then subjected to another round of screening by ELISA. Hybridomas with the highest signal were grown in 250 mL serum-free media (Gibco) for approximately one month. Secreted mAbs were purified using a Protein G column (GE Healthcare) and concentrated for use in downstream assays.
+ Open protocol
+ Expand
7

Purification of Monoclonal Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hybridoma cells were cultured in serum-free media (Gibco) with agitation on a shaker at 100 RPM in a chamber supplemented with 5% CO2 for 72 h. The conditioned media were collected, and cell debris were removed by centrifugation at 13,000 × g for 30 min. The remaining debris were finally removed by filtration through a 0.22-μm syringe filter (Millipore). The filtrates were purified on a HiTrap™ Protein G HP column (GE Healthcare Life Sciences) using an FPLC system (AKTA purifier, GE Healthcare Life Sciences). The column was equilibrated with PBS buffer at a flow rate of 1 min/ml, and bound proteins were eluted with 50 mM glycine-HCl (pH 2.5) at a flow rate of 3 ml/min. The eluted fractions were neutralized with 1 M Tris-HCl (pH 8.0) and then mixed with a protein-stabilizing cocktail solution (Thermo Fisher Scientific) prior to storage at −20 °C. Isotyping of the purified antibodies was performed using a mouse immunoglobulin isotyping kit (Antagen Pharmaceuticals). The protein concentration was adjusted to 1.0 μg/ml with PBS, and 50 μl of protein solutions were dropped into the sample-loading slots. The isotype was determined by the position of the red line formed.
+ Open protocol
+ Expand
8

In Vitro Analysis of 1E10Fc Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro analysis of 1E10Fc activity, cells were plated and incubated in 10 mL serum-free media (Gibco) overnight. Cells were then treated with 1 μM 1E10Fc or isotype control antibody for 15 min, followed by activation with PDGF-AA (1 nM, ThermoFisher) for an additional 15 min. Cells were washed with PBS and scraped in the following buffer for lysis: RIPA buffer (Sigma) containing cOmplete™ Protease Inhibitor Cocktail (Roche), PhosSTOP™ phosphatase inhibitor tablet (Roche), aprotinin (Sigma), and PMSF (Sigma). Lysates were also obtained from the homogenized tumor samples. Odyssey® Blocking Buffer (LiCor) in TBS was used for blocking and as diluent for the antibodies. Samples were run on Mini-PROTEAN® TGX™ Precast Gels (BioRad) at 100 V for 1.5 h and transferred to nitrocellulose membrane (ThermoFisher) via a wet transfer at 250 mV for 2 h. Membranes were blotted for expression of phosphorylated (1:2000, Cell Signaling #4060) and total AKT (1:1000, Cell Signaling #9272), a downstream target of PDGFRα signaling. GAPDH was used as the loading control (1:10,000, Proteintech #60004-1-Ig). IRDye® 800CW goat anti-mouse (1:10,000, LiCor # 925-32210) and IRDye® 680RD goat anti-rabbit (1,10,000, LiCor #925-68071) secondary antibodies were used. Blots were imaged and quantified on the Odyssey® CLx Imaging System (LiCor).
+ Open protocol
+ Expand
9

Molecular Constructs for mTOR Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
cDNA for S6K1 and 4EBP1-GFPSpark constructs were obtained from Sino Biological (China); mCherry-raptor, YFP-mTOR, YFP-PRAS40 and FLAG-mTOR from Addgene (USA). EGFP-mTOR, mDsRed-Rheb, EGFP-Rheb and mDsRed-raptor constructs were cloned previously21 (link). Miniprep and Maxiprep kits purchased from Qiagen (Germany). Rapamycin, L-leucine, L-serine and Ponceau S stain were purchased from Sigma-Aldrich (USA).
HEK293 cell line was purchased from ATCC® (USA), tested for mycoplasma contamination, and HEK293F cells were provided by Evotec (UK) Ltd. Cell culture dishes (35 mm × 20 mm) were bought from MatTek (USA).
HEK293 and HEK293T cells were cultured in Minimum Essential Media (MEM) supplemented with 10% Foetal Bovine Serum (FBS), 2 mM L-glutamine and 1% Penicillin-Streptomycin (P/S) for HEK293. HEK293F cells were grown in serum-free media (Gibco/Life Technologies, UK). All culture reagents were from Life Technologies. Cells were incubated at 37 °C with 5% CO2 humidified air in T75 culture flasks (Thermo Fisher Scientific, UK) or in 50 mL tubes (Corning®). SF9 cells were cultured in SF 900 III media supplemented with 1% P/S at 26 °C.
+ Open protocol
+ Expand
10

SARS-CoV-2 Antiviral Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero cells were seeded at 1.2 × 104 cells in 384-well, μClear plates (Greiner Bio-One, Kremsmünster, Austria) 24 h prior to the experiment. Compounds were placed in intermediate 384-well plates containing serum-free media (Gibco, Waltham, MA, USA). The diluted compounds (10 concentrations, 0.05–25 μM) were added to the cell plates in 10 μL volumes (at a final DMSO concentration of 0.5% (v/v)). For viral infection, plates were moved into the BSL-3 containment facility, and SARS-CoV-2 was added to the Vero cells at a multiplicity of infection (MOI) of 0.0125. At 24 h post-infection, the cells were fixed with 4% paraformaldehyde and stained with SARS-CoV-2 nucleocapsid protein, and immunofluorescence analysis was performed. To quantify the number of cells and infection ratios, Columbus software (PerkinElmer, Waltham, MA, USA) was used, and antiviral activity was normalized to the positive (mock-infected) and negative (0.5% DMSO) controls in each assay plate. Concentration–response curves were fitted by sigmoidal models using XLfit 4 in Microsoft Excel or GraphPad Prism 6.0 software (GraphPad Software, San Diego, CA, USA). The IC50 values were calculated from curves fitted to the normalized activity dataset. The quality of each assay was controlled by the Z′-factor [25 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!